Table: RaQualia Pharma - 6-MTH group results

RaQualia Pharma

14/08/2020 07:00

Aug 14 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Jun 30, 2020        Jun 30, 2019      Dec 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            372 mln             545 mln            1.58      
                 (-31.7 pct)         (+22.4 pct)       (-7.2 pct)   
  Operating     loss 403 mln        loss 302 mln      loss 260 mln  
  Recurring     loss 402 mln        loss 307 mln      loss 256 mln  
  Net           loss 459 mln        loss 310 mln      loss 333 mln  
  EPS          loss 21.93 yen      loss 15.19 yen    loss 15.93 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T